BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,203,246 | -25.2% | 50,031 | -0.7% | 0.00% | – |
| Q2 2023 | $1,608,473 | +3.7% | 50,375 | -0.6% | 0.00% | – |
| Q1 2023 | $1,551,117 | +20.3% | 50,657 | +53.6% | 0.00% | – |
| Q4 2022 | $1,289,496 | -5.8% | 32,971 | +14.7% | 0.00% | – |
| Q3 2022 | $1,369,000 | +39.7% | 28,752 | +13.6% | 0.00% | – |
| Q2 2022 | $980,000 | -23.3% | 25,311 | +13.5% | 0.00% | – |
| Q1 2022 | $1,278,000 | -27.2% | 22,307 | +1.3% | 0.00% | – |
| Q4 2021 | $1,756,000 | -13.5% | 22,030 | -5.6% | 0.00% | -100.0% |
| Q3 2021 | $2,030,000 | -17.3% | 23,335 | +22.3% | 0.00% | 0.0% |
| Q2 2021 | $2,456,000 | +200.2% | 19,082 | +86.7% | 0.00% | – |
| Q1 2021 | $818,000 | -94.5% | 10,218 | -94.4% | 0.00% | -100.0% |
| Q4 2020 | $14,909,000 | – | 182,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |